Multi-Industry Comments on FDA's Tool for the Prioritization of Food Chemicals for Post-Market Assessment
In August 2025, ASTA signed onto comments written by the Food & Beverage Issue Alliance (FBIA) encouraging FDA to leverage a science-driven, iterative approach for the prioritization of chemicals for post-market assessments. The comments call for FDA to place greater weight on public health risk-related factors, differentiate prioritization and assessment frameworks between intentionally added substances and contaminants, and to enhance transparency and stakeholder engagement opportunities.
08/19/2025 at 12:00 am
0
Related Resources
ASTA Draft Risk Profile Comments
ASTA issued a comment to the Food and Drug Administration (FDA) in March 2014 regarding the FDA's Draft Risk Profile on Pathogens and Filth in Spice.
ASTA Comments to FDA on Voluntary Sesame Labeling Guidance
ASTA issued comments to the Food and Drug Administration (FDA) in February 2021 on the Voluntary Disclosure of Sesame as an Allergen: Guidance for Industry. Comments outline inconsistencies and confusion arising from the guidance, including that FDA policy already provides that sesame should not be labeled under the generic declaration of spices. ASTA requests that FDA revoke the voluntary guidance due to the legislative process and the FASTER Act.
